Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Share Price
Equities
002399
CNE100000P02
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.22 CNY | +0.33% | +2.56% | -21.40% |
Sales 2024 * | 5.63B 777M 64.74B | Sales 2025 * | 6.47B 894M 74.48B | Capitalization | 12.15B 1.68B 140B |
---|---|---|---|---|---|
Net income 2024 * | 649M 89.57M 7.47B | Net income 2025 * | 739M 102M 8.5B | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | 67.8M 9.36M 780M | Net Debt 2025 * | 4.03B 556M 46.37B | EV / Sales 2025 * | 2.63 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
18.4
x | Employees | 2,080 |
Yield 2024 * |
0.54% | Yield 2025 * |
0.65% | Free-Float | 17.01% |
1 day | +0.33% | ||
1 week | +2.56% | ||
Current month | +10.42% | ||
1 month | +8.98% | ||
3 months | +1.32% | ||
6 months | -24.49% | ||
Current year | -21.40% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Shan
FOU | Founder | 64 | 21/98/21 |
Tan Li
FOU | Founder | 60 | 21/98/21 |
Juan Chen
DFI | Director of Finance/CFO | 49 | 21/23/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tan Li
FOU | Founder | 60 | 21/98/21 |
Peng Huang
BRD | Director/Board Member | 75 | 22/23/22 |
Li Li
FOU | Founder | 60 | 21/98/21 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 9.22 | +0.33% | 5,152,012 |
25/24/25 | 9.19 | +2.68% | 4,711,676 |
24/24/24 | 8.95 | +1.02% | 2,884,960 |
23/24/23 | 8.86 | -1.12% | 3,106,423 |
22/24/22 | 8.96 | -0.33% | 4,246,516 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.40% | 1.68B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 002399 Stock